Inhibikase Therapeutics, Inc.’s Post

Inhibikase will report financial results for the second quarter ended June 30, 2024, on Wednesday, August 14, 2024, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 15, 2024, to provide a corporate update and review the financial results. https://bit.ly/46DSVMz

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics